3048eP Preclinical evaluation of an anti-PD-L1/VEGF-A bispecific antibody CVL006 and its therapeutic potentials in combo with ADCs
Xiaoying Shen(University of California, Los Angeles), Zheng Wu(Shantou University), Jian Xu(University of California, Los Angeles), Zhengbo Song(Chinese Academy of Sciences), Zheng Wang(Shanghai Jiao Tong University), Cheng Wang(Qingdao University), Zhong Li(Nanjing Forestry University), Jingyu Huang(Convalife (China)), He Huang(Harbin Medical University), Jiajia Pan(Yangzhou University), Lu Cao(Chinese People's Liberation Army)
Cited by 0
Related Papers
Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA
|Cell Research|2011|1.2k
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
|Gastric Cancer|2014|615
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
Updating the East Asian mtDNA phylogeny: a prerequisite for the identification of pathogenic mutations
|Human Molecular Genetics|2006|390